MENU
DFTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Definium Therapeutics (DFTX) Earnings Date & Reports
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction... Show more
A.I. Advisor
published Earnings
DFTX is expected to report earnings to fall 61.81% to -55 cents per share on November 05
Q3'26
Est.
$-0.55
Q2'26
Missed
by $0.96
Q1'26
Missed
by $0.23
Q4'25
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -144 cents, missing the estimate of -47 cents. With 643.71K shares outstanding, the current market capitalization sits at 4.77B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
One World Trade Center
Phone
+1 212 220-6633
Employees
106
Web
https://www.definiumtx.com